CASP1 and non-small cell lung carcinoma: Wang had found that caspase-1 dependent pyroptosis induced by the lipid-lowering drug simvastatin occurred in lung cancer cells, indicating that simvastatin might be a potential drug for clinical treatment of NSCLC [15].